| Product Code: ETC10765547 | Publication Date: Apr 2025 | Updated Date: Feb 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Spain`s import trend for pemetrexed showed a steady increase, driven by rising demand in the pharmaceutical sector. Imports of pemetrexed into Spain experienced a notable growth trajectory, reflecting the country`s reliance on international sources for this essential drug.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Spain Pemetrexed Market Overview |
3.1 Spain Country Macro Economic Indicators |
3.2 Spain Pemetrexed Market Revenues & Volume, 2022 & 2032F |
3.3 Spain Pemetrexed Market - Industry Life Cycle |
3.4 Spain Pemetrexed Market - Porter's Five Forces |
3.5 Spain Pemetrexed Market Revenues & Volume Share, By Indication, 2022 & 2032F |
3.6 Spain Pemetrexed Market Revenues & Volume Share, By Mechanism of Action, 2022 & 2032F |
3.7 Spain Pemetrexed Market Revenues & Volume Share, By Combination Therapy, 2022 & 2032F |
3.8 Spain Pemetrexed Market Revenues & Volume Share, By End User, 2022 & 2032F |
3.9 Spain Pemetrexed Market Revenues & Volume Share, By Administration Route, 2022 & 2032F |
4 Spain Pemetrexed Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of lung cancer in Spain |
4.2.2 Rising adoption of advanced chemotherapy treatments |
4.2.3 Government initiatives to improve access to cancer care |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval |
4.3.2 Competition from alternative treatment options |
4.3.3 Economic uncertainties impacting healthcare spending |
5 Spain Pemetrexed Market Trends |
6 Spain Pemetrexed Market, By Types |
6.1 Spain Pemetrexed Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Spain Pemetrexed Market Revenues & Volume, By Indication, 2022 - 2032F |
6.1.3 Spain Pemetrexed Market Revenues & Volume, By Non-Small Cell Lung Cancer, 2022 - 2032F |
6.1.4 Spain Pemetrexed Market Revenues & Volume, By Mesothelioma, 2022 - 2032F |
6.1.5 Spain Pemetrexed Market Revenues & Volume, By Breast Cancer, 2022 - 2032F |
6.1.6 Spain Pemetrexed Market Revenues & Volume, By Colorectal Cancer, 2022 - 2032F |
6.1.7 Spain Pemetrexed Market Revenues & Volume, By Pancreatic Cancer, 2022 - 2032F |
6.2 Spain Pemetrexed Market, By Mechanism of Action |
6.2.1 Overview and Analysis |
6.2.2 Spain Pemetrexed Market Revenues & Volume, By Antifolate, 2022 - 2032F |
6.2.3 Spain Pemetrexed Market Revenues & Volume, By DNA Synthesis Inhibition, 2022 - 2032F |
6.2.4 Spain Pemetrexed Market Revenues & Volume, By Enzyme Targeting, 2022 - 2032F |
6.2.5 Spain Pemetrexed Market Revenues & Volume, By Cell Growth Suppression, 2022 - 2032F |
6.2.6 Spain Pemetrexed Market Revenues & Volume, By Purine Synthesis Blockade, 2022 - 2032F |
6.3 Spain Pemetrexed Market, By Combination Therapy |
6.3.1 Overview and Analysis |
6.3.2 Spain Pemetrexed Market Revenues & Volume, By Platinum-Based Chemotherapy, 2022 - 2032F |
6.3.3 Spain Pemetrexed Market Revenues & Volume, By Immunotherapy, 2022 - 2032F |
6.3.4 Spain Pemetrexed Market Revenues & Volume, By Radiation Therapy, 2022 - 2032F |
6.3.5 Spain Pemetrexed Market Revenues & Volume, By Personalized Medicine, 2022 - 2032F |
6.3.6 Spain Pemetrexed Market Revenues & Volume, By Monoclonal Antibodies, 2022 - 2032F |
6.4 Spain Pemetrexed Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Spain Pemetrexed Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.4.3 Spain Pemetrexed Market Revenues & Volume, By Oncology Clinics, 2022 - 2032F |
6.4.4 Spain Pemetrexed Market Revenues & Volume, By Specialty Clinics, 2022 - 2032F |
6.4.5 Spain Pemetrexed Market Revenues & Volume, By Research Institutes, 2022 - 2032F |
6.4.6 Spain Pemetrexed Market Revenues & Volume, By Pharmaceutical Companies, 2022 - 2032F |
6.5 Spain Pemetrexed Market, By Administration Route |
6.5.1 Overview and Analysis |
6.5.2 Spain Pemetrexed Market Revenues & Volume, By Intravenous, 2022 - 2032F |
6.5.3 Spain Pemetrexed Market Revenues & Volume, By Injection, 2022 - 2032F |
6.5.4 Spain Pemetrexed Market Revenues & Volume, By IV Infusion, 2022 - 2032F |
6.5.5 Spain Pemetrexed Market Revenues & Volume, By Cancer Treatment Centers, 2022 - 2032F |
6.5.6 Spain Pemetrexed Market Revenues & Volume, By Hospital Pharmacy, 2022 - 2032F |
7 Spain Pemetrexed Market Import-Export Trade Statistics |
7.1 Spain Pemetrexed Market Export to Major Countries |
7.2 Spain Pemetrexed Market Imports from Major Countries |
8 Spain Pemetrexed Market Key Performance Indicators |
8.1 Patient survival rates post-pemetrexed treatment |
8.2 Rate of adoption of pemetrexed in lung cancer treatment protocols |
8.3 Number of clinical trials involving pemetrexed in Spain |
9 Spain Pemetrexed Market - Opportunity Assessment |
9.1 Spain Pemetrexed Market Opportunity Assessment, By Indication, 2022 & 2032F |
9.2 Spain Pemetrexed Market Opportunity Assessment, By Mechanism of Action, 2022 & 2032F |
9.3 Spain Pemetrexed Market Opportunity Assessment, By Combination Therapy, 2022 & 2032F |
9.4 Spain Pemetrexed Market Opportunity Assessment, By End User, 2022 & 2032F |
9.5 Spain Pemetrexed Market Opportunity Assessment, By Administration Route, 2022 & 2032F |
10 Spain Pemetrexed Market - Competitive Landscape |
10.1 Spain Pemetrexed Market Revenue Share, By Companies, 2025 |
10.2 Spain Pemetrexed Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here